| Robert Ecker Dds David J Engelson Dds Pc | |
|
1579 Brentwood Rd Bayshore NY 11706 | |
| (631) 665-8484 | |
| (631) 665-3953 |
| Full Name | Robert Ecker Dds David J Engelson Dds Pc |
|---|---|
| Speciality | Dentist |
| Location | 1579 Brentwood Rd, Bayshore, New York |
| Authorized Official Name and Position | David J Engelson (VP) |
| Authorized Official Contact | 6316658484 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Robert Ecker Dds David J Engelson Dds Pc 1579 Brentwood Rd Bayshore NY 11706 Ph: (631) 665-8484 | Robert Ecker Dds David J Engelson Dds Pc 1579 Brentwood Rd Bayshore NY 11706 Ph: (631) 665-8484 |
| NPI Number | 1528020583 |
|---|---|
| Provider Enumeration Date | 04/05/2006 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528020583 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 024430 (New York) | Primary |
| 122300000X | Dentist | 024886 (New York) | Secondary |
News Archive
When it comes to skin infections, a healthy and robust immune response may depend greatly upon what lies beneath. In a new paper published in the January 2, 2015 issue of Science, researchers at the University of California, San Diego School of Medicine report the surprising discovery that fat cells below the skin help protect us from bacteria.
Loyola University Medical Center researchers have published the first ever study of emotional and psychological anguish, known as "moral distress," experienced by nurses in an intensive care unit for burn patients.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).
Studies Conducted at INRA-Agroparistech Laboratory Under Pr. Daniel Tome's Supervision and Published in November 2009, in the Official Journal of the International Bone and Mineral Society "Bone", Reveal new Benefits for Peptan(TM) in Osteoporosis Prevention
One of the nation's leading cardiovascular medical researchers has issued a call for less aggressive direct-to-consumer advertising and better safety assurances of medications in a special article posted online by JAMA because of its relevance to the recent withdrawals and warning labels on the pain-relieving drugs known as COX-2 inhibitors.
› Verified 1 days ago